Literature DB >> 11775071

Establishment and partial characterization of a continuous human malignant glioma cell line: NG97.

M C Grippo1, P F Penteado, E F Carelli, M A Cruz-Höfling, L Verinaud.   

Abstract

1. A human glioma cell line, NG97, was established from tissue obtained from a patient diagnosed with a grade III astrocytoma. 2. The NG97 cell line has been subcultured for more than 100 passages in standard culture media without feeder layer or collagen coatings. 3. NG97 cells grow in vitro as two subpopulations with distinct morphological appearance: stellate cells with pleomorphic nuclei, and small round cells with few processes. The cells have a doubling time of about 72 h and a plating efficiency of 1%. The injection of NG97 cells into congenitally athymic mice induced the formation of solid tumor masses that could be retransplanted every 4 weeks. The cells obtained from tumor mass when cultivated in vitro had a morphology comparable to those of the initial culture. 4. This cell line may prove useful for cellular and molecular studies as well as in studies of gliomas treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11775071     DOI: 10.1023/a:1012662423863

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  11 in total

1.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

Authors:  I MACPHERSON; L MONTAGNIER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA.

Authors:  A Perzelová; I Máciková; P Mráz; I Bízik; J Steno
Journal:  Neoplasma       Date:  1998       Impact factor: 2.575

3.  Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.

Authors:  K Onda; S Nagai; R Tanaka; K Morii; J I Yoshimura; I Tsumanuma; T Kumanishi
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

4.  Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.

Authors:  U Pohl; W Wick; J Weissenberger; J P Steinbach; J Dichgans; A Aguzzi; M Weller
Journal:  Int J Oncol       Date:  1999-10       Impact factor: 5.650

5.  Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.

Authors:  H Halfter; J Kremerskothen; J Weber; U Hacker-Klom; A Barnekow; E B Ringelstein; F Stögbauer
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

6.  Characterization of an established human malignant glioma cell line: LN-18.

Authors:  A C Diserens; N de Tribolet; A Martin-Achard; A C Gaide; J F Schnegg; S Carrel
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).

Authors:  A Martin-Achard; A C Diserens; N de Tribolet; S Carrel
Journal:  Int J Cancer       Date:  1980-02-15       Impact factor: 7.396

8.  Surface antigenic characteristics of human glial brain tumor cells.

Authors:  C J Wikstrand; M S Mahaley; D D Bigner
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

9.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

10.  Establishment and characterization of a typical primitive neuroectodermal tumor cell line.

Authors:  H Horiguchi; M Matsui; R Ohtsubo; T Ogata; M Kaneko; M Fujiwara; H Kamma
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723

View more
  8 in total

1.  Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line.

Authors:  André A Schenka; Camila M L Machado; Mariângela C Grippo; Luciano S Queiroz; Natália G M Schenka; Cristiano A Chagas; Liana Verinaud; Pierre Brousset; José Vassallo
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

2.  Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme.

Authors:  Jiagui Qu; Joshua D Rizak; Yaodong Fan; Xiaoxuan Guo; Jiejing Li; Tanzeel Huma; Yuanye Ma
Journal:  Hum Cell       Date:  2014-01-04       Impact factor: 4.174

3.  Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization.

Authors:  Jing Wang; Xiujie Wang; Shu Jiang; Ping Lin; Jie Zhang; Yaying Wu; Zhujuan Xiong; Jing Jing Ren; Hongliang Yang
Journal:  Cell Mol Neurobiol       Date:  2007-08-17       Impact factor: 5.046

Review 4.  In vivo models of primary brain tumors: pitfalls and perspectives.

Authors:  Peter C Huszthy; Inderjit Daphu; Simone P Niclou; Daniel Stieber; Janice M Nigro; Per Ø Sakariassen; Hrvoje Miletic; Frits Thorsen; Rolf Bjerkvig
Journal:  Neuro Oncol       Date:  2012-06-07       Impact factor: 12.300

5.  Morphological characterization of a human glioma cell l ine.

Authors:  Camila Ml Machado; André Schenka; José Vassallo; Wirla Msc Tamashiro; Estela M Gonçalves; Selma C Genari; Liana Verinaud
Journal:  Cancer Cell Int       Date:  2005-05-10       Impact factor: 5.722

6.  Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.

Authors:  Rafael Yamashita Ikemori; Camila Maria Longo Machado; Karina Mie Furuzawa; Suely Nonogaki; Eduardo Osinaga; Kazuo Umezawa; Marcelo Alex de Carvalho; Liana Verinaud; Roger Chammas
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancer.

Authors:  Natália Barreto; Marcus Caballero; Amanda Pires Bonfanti; Felipe Cezar Pinheiro de Mato; Jaqueline Munhoz; Thomaz A A da Rocha-E-Silva; Rafael Sutti; João Luiz Vitorino-Araujo; Liana Verinaud; Catarina Rapôso
Journal:  Cancer Cell Int       Date:  2020-12-17       Impact factor: 5.722

8.  Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro.

Authors:  Camila M L Machado; Rafael Y Ikemori; Tatiana Q Zorzeto; Ana C M A Nogueira; Suse D S Barbosa; Wilson Savino; André A Schenka; José Vassallo; Juliana K Heinrich; Fátima Boetcher-Luiz; Liana Verinaud
Journal:  BMC Cancer       Date:  2008-10-08       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.